WallStreetZenWallStreetZen

NASDAQ: ATXI
Avenue Therapeutics Inc Stock Ownership - Who owns Avenue Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Avenue Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Robert L. Davidow10% Owner2023-12-1120,000$0.14
$2.80kSell
Robert L. Davidow10% Owner2023-12-11128,000$0.14
$17.92kSell
Robert L. Davidow10% Owner2023-12-11126,000$0.14
$17.64kSell
Robert L. Davidow10% Owner2023-12-1161,000$0.14
$8.54kSell
Robert L. Davidow10% Owner2023-12-1118,000$0.15
$2.70kSell
Robert L. Davidow10% Owner2023-12-11264,000$0.14
$36.96kSell
Fortress Biotech Inc10% Owner2023-09-08418,410$0.72
$301.26kBuy
Lindsay A. Md RosenwaldDirector2023-09-08348,675$0.72
$251.05kBuy

1 of 1

ATXI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATXI insiders and whales buy or sell their stock.

ATXI Shareholders

What type of owners hold Avenue Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fortress Biotech Inc8.01%3,547,393$333.45kInsider
Robert L. Davidow2.96%1,309,800$123.12kInsider
Lucy Lu1.69%748,949$70.40kInsider
Lindsay A. Md Rosenwald0.80%354,318$33.31kInsider
Invagen Pharmaceuticals Inc0.56%250,000$23.50kInsider
Neil Herskowitz0.42%183,744$17.27kInsider
Joseph Walter Vazzano0.37%165,757$15.58kInsider
Jay D. Kranzler0.30%133,683$12.57kInsider
Citadel Advisors LLC0.20%88,645$8.33kInstitution
Jeffrey Paley0.18%79,663$7.49kInsider

1 of 3

ATXI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATXI0.73%15.75%Net Buying
XRTX100.00%0.00%
GTBP73.85%26.15%Net Buying
HOTH0.94%99.06%
PXMD1.39%98.61%Net SellingNet Selling
View Top Biotech Stocks

Avenue Therapeutics Stock Ownership FAQ

Who owns Avenue Therapeutics?

Avenue Therapeutics (NASDAQ: ATXI) is owned by 0.73% institutional shareholders, 15.75% Avenue Therapeutics insiders, and 83.51% retail investors. Fortress Biotech Inc is the largest individual Avenue Therapeutics shareholder, owning 3.55M shares representing 8.01% of the company. Fortress Biotech Inc's Avenue Therapeutics shares are currently valued at $415.04k.

If you're new to stock investing, here's how to buy Avenue Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.